IEEE-ACM Transactions on Computational Biology and Bioinformatics is a prestigious journal published by the IEEE Computer Society, focusing on the interdisciplinary field of computational biology and bioinformatics. Established in 2004, this journal has made significant strides in contributing to our understanding of complex biological systems through quantitative methods and computational techniques, and it spans a converged publication period through 2024. As a notable resource with an impact factor that positions it in the second quartile in the domains of Applied Mathematics, Biotechnology, and Genetics, it serves as an essential platform for researchers and professionals seeking to disseminate their findings to a global audience. The journal ranks impressively in Scopus, with Applied Mathematics holding a rank of #38 out of 635 (94th percentile) and Genetics at #86 out of 347 (75th percentile), highlighting its significant influence in the scientific community. While the journal is not open-access, it provides valuable insights and cutting-edge research that are crucial for advancing the fields of bioinformatics and computational biology, making it indispensable for students, researchers, and practitioners alike.

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.

Computational and Structural Biotechnology Journal is a premier open-access journal published by Elsevier, focusing on the intersection of computer science and molecular biology. Since its inception in 2012, the journal has established itself as a leading platform for innovative research, featuring groundbreaking studies in biochemistry, biophysics, biotechnology, and genetics. With a remarkable Q1 ranking in multiple categories, including Biochemistry and Genetics, it stands out for its high impact, evidenced by its strong Scopus ranking percentile scores. As a vital resource for researchers, professionals, and students, the journal aims to foster the dissemination of essential findings that leverage computational techniques to explore complex biological systems. In a rapidly evolving scientific landscape, Computational and Structural Biotechnology Journal serves as an indispensable resource for those looking to contribute and stay abreast of major advancements in the field.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

Network Modeling and Analysis in Health Informatics and Bioinformatics, published by SPRINGER WIEN, stands as a vital resource in the interdisciplinary domains of health informatics and bioinformatics. With an ISSN of 2192-6662 and E-ISSN of 2192-6670, this journal aims to facilitate the dissemination of innovative research that intersects network modeling, data analysis, and health applications. The journal competes at a Q3 quartile level across multiple categories including Biomedical Engineering and Health Informatics, showcasing its growing influence within the academic community. As of 2023, it holds impressive Scopus rankings, including a 20th position in Urology, illustrating its significance in the field. Although not an open access publication, the journal is dedicated to providing cutting-edge insights from 2012 to 2024 and is poised to attract researchers, professionals, and students striving to push the boundaries of knowledge in health informatics and bioinformatics. This journal is not just a platform for sharing scholarly articles; it is a catalyst for advancing methodologies that enhance patient care and medical research.

Frontiers in Bioinformatics is a leading academic journal dedicated to advancing the field of bioinformatics by publishing high-quality research and review articles. Published by FRONTIERS MEDIA SA, this open-access journal aims to foster innovative research, promote collaborative initiatives, and provide a platform for the dissemination of findings related to computational biology, biostatistics, and the intersection of bioinformatics with other biological disciplines. With a focus on promoting accessibility and visibility of research, Frontiers in Bioinformatics operates under a rigorous peer-review process, ensuring that all published content meets the highest academic standards. The journal has shown a commendable rank across various Scopus categories, including Mathematics, Computational Mathematics, and multiple dimensions of Biochemistry and Molecular Biology, indicating its relevance and impact within the research community. Researchers, professionals, and students will find this journal invaluable for staying abreast of the latest developments and breakthroughs in bioinformatics, enhancing their studies and professional projects.

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

BioData Mining is a distinguished open access journal published by BMC, focusing on the dynamic intersection of bioinformatics, computational mathematics, and molecular biology. Since its inception in 2008, this journal has provided a critical platform for researchers and professionals to publish their findings, contributing significantly to the collective knowledge in fields such as biochemistry, computational theory, and genetics. With a robust impact factor and a commendable h-index, BioData Mining continues to be a vital resource for academic and industrial advancements, ranked in the top quartiles in various categories according to the 2023 metrics. The journal's commitment to open access ensures that cutting-edge research is readily available to the global scientific community, thereby enhancing visibility and fostering collaboration among scholars. Whether you are a researcher, student, or practitioner, engaging with BioData Mining will equip you with relevant insights and developments in the fast-evolving realm of bioinformatics.

Briefings in Functional Genomics, published by Oxford University Press, serves as a crucial academic resource in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 2041-2649 and an E-ISSN of 2041-2657, this esteemed journal explores innovative research and developments in functional genomics, with a commitment to advancing our understanding of genetic processes and their implications in health and disease. Ranking in the Q2 quartile for both Biochemistry and Genetics, and occupying a prominent Q1 status in the domain of interdisciplinary Medicine, the journal is positioned as a leading platform for researchers seeking to disseminate their findings to a global audience. Although it does not currently offer open access options, its accessibility through institutional subscriptions and its esteemed impact factor underscore its importance in the research community. Covering converging topics from 2010 to 2024, Briefings in Functional Genomics not only keeps pace with the rapidly evolving landscape of genomics but also stimulates collaboration and dialogue among scientists and industry professionals alike, making it an indispensable tool for researchers, practitioners, and students eager to engage with cutting-edge genomic science.